Dermatology · Saint Louis, MO
NPI
1073660957
Since 2007
Specialty
Dermatology
Code 207N00000X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
4901 Forest Park Ave, Div Im Dermatology, Ste 502
Saint Louis, MO, 63108
Phone (314) 273-3376
Groups this clinician bills Medicare through
Medicare paid, 2024
$108K
3,031 services
Medicare patients, 2024
613
Average age 72
Drug cost, 2024
$1.7M
2,349 prescriptions
Company payments, 2025
$1,852
From 2 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy C Musiek was code 17003 (destruction skin lesion), 433 times for 105 patients. In total Amy C Musiek billed 3,031 services in 48 codes, and Medicare paid $108K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-04-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 17003 Destruction Skin Lesion | Office | 433 | 105 | $4.73 | $2,047 |
| 99213 Office E&M - Established | Office | 321 | 287 | $59.35 | $19K |
| 99214 Office E&M - Established | Office | 286 | 194 | $89.23 | $26K |
| J3301 Injection, triamcinolone acetonide, not otherwise specified, 10 mg | Office | 191 | 15 | $0.73 | $139 |
| 17000 Destruction Skin Lesion | Office | 184 | 155 | $36.97 | $6,803 |
| 17110 Destruction Skin Lesion | Office | 95 | 89 | $77.52 | $7,365 |
| 96910 Skin | Office | 84 | 11 | $87.21 | $7,326 |
| 11102 Skin Biopsy | Office | 82 | 65 | $70.89 | $5,813 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 60 | 33 | $12.63 | $758 |
| 99232 Hospital E&M - Subsequent | Facility | 53 | 41 | $60.27 | $3,194 |
| 99222 Hospital E&M - Initial | Facility | 48 | 48 | $94.96 | $4,558 |
| 11900 Skin | Office | 39 | 16 | $38.10 | $1,486 |
| 99215 Office E&M - Established | Office | 36 | 14 | $138.46 | $4,985 |
| 99204 Office E&M - New | Office | 28 | 28 | $118.90 | $3,329 |
| 11104 Skin Biopsy | Office | 28 | 27 | $92.24 | $2,583 |
By year: 2022 $113K for 1,959 services; 2023 $106K for 1,921 services; 2024 $108K for 3,031 services.
Medicare prescription drug claims, 2024
In 2024, the drug Amy C Musiek prescribed most often to Medicare patients was Triamcinolone Acetonide, with 254 prescriptions and refills. In total Amy C Musiek wrote 2,349 Medicare prescriptions that cost $1.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Triamcinolone Acetonide Generic | 254 | 289 | 114 | $4,206 |
| Clobetasol Propionate Generic | 223 | 251 | 90 | $11K |
| Ketoconazole Generic | 180 | 189 | 64 | $2,713 |
| Hydrocortisone Generic | 123 | 133 | 56 | $762 |
| Clindamycin Phosphate Generic | 114 | 115 | 30 | $4,161 |
| Doxycycline Hyclate Generic | 105 | 122 | 33 | $2,603 |
| Prednisone Generic | 85 | 103 | 38 | $454 |
| Gabapentin Generic | 74 | 101 | 19 | $864 |
| Dupixent Pen Dupilumab | 68 | 73 | Under 11 | $292K |
| Bexarotene Generic | 63 | 63 | Under 11 | $106K |
| Metronidazole Generic | 60 | 65 | 25 | $2,658 |
| Tretinoin Generic | 58 | 63 | 19 | $4,155 |
| Mupirocin Generic | 55 | 55 | 26 | $383 |
| Minoxidil Generic | 52 | 87 | 11 | $382 |
| Hydroxychloroquine Sulfate Generic | 46 | 90 | Under 11 | $1,283 |
Brand drugs: 289 claims; generic drugs: 2,060 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy C Musiek $1,852 ($1,852 in general payments such as food, travel and fees) from 2 companies. The largest payer was Kyowa Kirin, Inc. with $1,852.
| Company | Payments | Amount |
|---|---|---|
| Kyowa Kirin, Inc. 4151.T | 4 | $1,852 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.